Allife Medical Science and Technology
Main focus: Next generation cellular therapies
Company stage: Clinical
Diseases: Beta-thalassemia, hematological - and solid tumors
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: Beijing, China
Allife Medical Science and Technology is a company focused on developing next generation cellular therapies for the treatment of genetic diseases and cancers. The company uses CRISPR to genetically modify its cellular products, and currently runs multiple clinical trials.